Spruce Biosciences, Inc. (SPRB): Dana dhuwit perusahaan

Simbol resmi perusahaan Spruce Biosciences (SPRB)

Spruce Biosciences focuses on therapies for rare endocrine pathologies with lifelong demand. The change in cash reserves on GURU.Markets confirms this trajectory, where the current status is 0.09. Patents for tildeserfone serve as a defense, creating barriers for competitors, although the absence of commercial sales due to trial stages deprives the company of pricing power.

Total volume dana dhuwit perusahaan: Spruce Biosciences, Inc. (SPRB) kanggo 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Spruce Biosciences

- nilai saham lan prakiraan konsensus rega:
Analisis fundamental perusahaan:sprucebiosciences.com
Sampel barang sprucebiosciences.com

This indicator tracks the volume of liquid assets, determining the issuer's ability to fund operating activities without external borrowing. Investors analyze the burn rate to calculate the "cash runway" until the product reaches the market. The trend in cash reserves allows for an assessment of the risk of equity dilution during subsequent offerings. For Spruce Biosciences (SPRB), this resource is critical as it completes the development of unique drugs for adrenal hyperplasia. The absence of competitors guarantees high future margins provided that current solvency is maintained.

Pesaing Spruce Biosciences (SPRB)

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Soleno Therapeutics Inc SLNO|Dhuwit awis perusahaan FOLD (Amicus Therapeutics Inc)|ETNB (89bio Corp) - Sisa dhuwit perusahaan|Agios Pharmaceuticals - Dhuwit awis perusahaan|Gunggung dana dhuwit perusahaan GPCR (Structure Therapeutics Inc.)|MDXG: Dhuwit awis perusahaan|Rezolute - Gunggung dana dhuwit perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis perusahaan|Dhuwit awis perusahaan MBX Bio|Dhuwit awis perusahaan ALT|AARD: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SGMT|Dana dhuwit perusahaan BIOA (BioAge Labs)|Volume dana dhuwit perusahaan BMEA (Biomea Fusion Corp)|Sisa dhuwit perusahaan QNCX|GUTS - Dana dhuwit perusahaan|VTVT - Volume dana dhuwit perusahaan|Agape ATP Corp. (ATPC) - Dana dhuwit perusahaan|Pluri Inc (PLUR) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Synlogic|Dana dhuwit perusahaan LPCN|Dana dhuwit perusahaan Matinas BioPharma Holdings, Inc. (MTNB)|Gunggung dana dhuwit perusahaan GLTO|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)